Identification of the client-binding site on the Golgi membrane protein adaptor Vps74/yGOLPH3
Agnieszka M Lesniak
Ziyun Ye
David K Banfield
Corresponding author bodkb@ust.hk
These authors contributed equally
Lead contact
Received 2025 Mar 7; Revised 2025 Jun 29; Accepted 2025 Sep 1; Collection date 2025 Oct 17.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Summary
Vps74 and its mammalian counterpart GOLPH3 are COPI associated protein sorting adaptors that function to maintain the cisternal distributions of a diversity of Golgi integral membrane protein clients by binding to their short cytoplasmically exposed N-termini. Here, we identify the client-binding site on yeast GOLPH3 (Vps74) which maps to two evolutionarily conserved loops on the membrane-facing surface, and includes residues mediating binding of GOLPH3s to PI4P, as well as the membrane-binding β hairpin. As an orthogonal approach, we isolated an inhibitory anti-Vps74 nanobody (which also binds to GOLPH3s) with which we corroborate the client-binding site and reveal that Sac1 and Arf1 binding to Vps74 blocks client access. We also identify an additional mode for the recruitment of Vps74 to Golgi membranes whereby the adaptor binds directly to its client N-termini. This study elucidates the molecular mechanism of Vps74 and identifies an inhibitory GOLPH3 nanobody with potential therapeutic applications.
Subject areas: Biochemistry, molecular biology, cell biology
Graphical abstract
Highlights
-
•
Vps74 sorts its Golgi membrane protein clients via N-terminal binding
-
•
Vps74 can directly bind client N-termini for membrane recruitment
-
•
The client-binding site is comprised of conserved loops and the PI4P-binding site
-
•
A nanobody blocks client binding revealing competition with Sac1 and Arf1
Biochemistry; Molecular biology; Cell biology
Introduction
The Golgi is the protein sorting hub of the cell and the functional and compositional integrity of this organelle relies on its capacity to discriminate resident from non-resident proteins.1 ,2 Golgi resident proteins are typically integral membrane proteins with roles in glycosylation of proteins and lipids, ion transport, proteolytic processing, and the synthesis and processing of lipids. In contrast to other intra-cellular organelles the Golgi is comprised of several sub-compartments termed cisterna and newly synthesized proteins are transported vectorially from cis, medial to trans whereupon they are successively and sequentially modified. The enzymes that modify nascent proteins are enriched in the cisterna in which they function, and thus in addition to discriminating between resident and non-resident proteins the Golgi also needs to maintain the correct cisternal distributions of its native proteins.1 ,2
A prevailing model for the retention of Golgi proteins is the cisternal maturation model which stipulates that cisternal identity is maintained through iterative cycles of capture and retrieval of resident proteins from trans to cis cisternae mediated in COPI-coatomer coated vesicles.3 ,4 ,5 The key question in understanding the maintenance of the compartmental protein composition of the Golgi has been to address how resident proteins are recognized, selected, and sorted into COPI vesicles. In addition to informing fundamental cell biology, defects in Golgi function are associated with human diseases including congenital defects in glycosylation, neurodegenerative diseases as well as a variety of cancers.6
To date, several Golgi protein sorting adaptors have been identified and they include GOLPH3 (Vps74 in yeast cells),7 ,8 ,9 ,10 Erd1,11 FAM114A2,12 and most recently LYSET.13 In the case of the GOLPH3s, the adaptor binds to comparatively short, cytoplasmically exposed N-termini of certain Golgi membrane proteins. The N-termini of GOLPH3’s clients vary somewhat in their length and amino acid sequence but in general appear to be comprised of a cluster of hydrophobic residues, or often positively charged amino acids such as lysine and arginine.7 ,9 ,10 Like GOLPH3s, FAM114A2 proteins appear to recognize a cluster of basic amino acids as well,12 whereas the features of Golgi residents recognized by Erd1 are presently unknown. LYSET is an atypical GOLPH3 client whose Golgi retention is critical for the sorting of some proteins to the lysosome.13 GOLPH3s bind directly to coatomer providing a mechanistic link between client-binding and incorporation into COPI vesicles.10 ,14 ,15
GOLPH3 is an oncogene.16 Amplification of GOLPH3 is observed in several cancers where it is associated with poor prognosis, revealing an important role for this Golgi protein in cancer progression.17 ,18 It was initially suggested that the oncogenic properties of GOLPH3 were related to enhanced activation of mTOR.16 ,19 However, more recently, the oncogenic role of GOLPH3 has been shown to involve its requirement for the retention of certain Golgi membrane proteins.7
The crystal structures of yeast and human GOLPH3s have been determined and they share a striking degree of similarity in their folded domain.8 ,20 From these structures it was surmised that GOLPH3s bind to PI4P, a phosphoinositide that is enriched in Golgi trans cisternae and in the trans Golgi network (TGN). Amino acid substitutions at the presumptive PI4P binding site resulted in loss of Golgi membrane binding and concomitant mislocalization of Vps74 clients from the Golgi to the vacuole. Further interrogation of features of the folded domain of Vps74/GOLPH3s revealed a role for the conserved β hairpin in membrane-binding. Thus, PI4P-binding and the hydrophobic tip of the protein’s β hairpin are likely to account for the GOLPH3s Golgi membrane localization. Although it is not known whether, either determinant will suffice or if PI4P and the β hairpin are both required for membrane recruitment.
Further structural and biochemical studies established that GOLPH3s bind to Sac1 (a PI4P phosphatase) and that GOLPH3s are Sac1 effector proteins.21 ,22 However, it remains to be established to what extent PI4P binding participates in adaptor—client-binding. The N-terminal region of the GOLPH3s varies in length from species to species and is likely to be intrinsically unstructured, nevertheless this region contains an evolutionarily conserved cluster of arginine residues that are critical for the adaptor’s binding to coatomer.15
Biochemical studies have shown that Vps74 binds to the coatomer-associated small GTPase Arf1.15 The association of Arf1 and Vps74 is mediated by the folded domain of Vps74 and requires that Arf1 be bound to GTP. The functional relevance of this interaction has not been investigated, but the necessity for Arf1-GTP suggests that the interaction with Vps74 occurs on Golgi membranes.
Importantly, it is not presently known where on GOLPH3s clients bind. This information is critical for extending our understanding of the molecular mechanisms by which membrane proteins are retained in the Golgi and will also inform therapeutic intervention strategies for GOLPH3s in cancer cells.
Herein we report identification of the client-binding site on the yeast GOLPH3 adaptor Vps74. Client-binding is mediated through two evolutionarily conserved membrane opposing loops, the PI4P binding site and the β hairpin suggesting that the mode of client-adaptor binding is likely to be conserved among GOLPH3s. Moreover, we establish that client over-expression is sufficient to recruit Vps74 to the Golgi. We further show that the binding site for clients on Vps74 overlaps with those for Sac1 and Arf1-GTP, findings that have important implications for the roles of Sac1 and Arf1-GTP in GOLPH3-mediated retention of Golgi membrane proteins. In an orthogonal approach we utilized an inhibitory anti-Vps74 nanobody in biochemical studies to corroborate the client-binding sites and to define the binding sites for Sac1 and Arf1 on Vps74.
Results
Vps74 localizes to multiple Golgi cisternae
Vps74 and its homologs (the GOLPH3) are widely distributed throughout eukaryotes. These proteins are peripheral Golgi membrane proteins that reportedly associate with membranes through their PI4P-binding site and/or through a conserved β hairpin.20 ,21 GOLPH3s function as COPI-coatomer adaptors that bind to the cytoplasmically exposed N-termini of numerous Golgi-resident integral membrane proteins.8 ,9 ,10 Hereafter we refer to these integral membrane proteins as clients. In addition to its client-binding ability, Vps74 reportedly stimulates the PI4P phosphatase activity of Sac1.21 ,22 Presumably, where Vps74 and Sac1 distributions overlap the prevalence of PI4P is likely to be reduced.21 Given that PI4P is found predominantly in the trans Golgi,23 ,24 ,25 but Vps74’s clients are distributed throughout the Golgi, how does Vps74 bind to Golgi membranes with comparatively little PI4P?
To begin to address this question, we generated Vps74 fusions to mNeon to visualize the protein in cells. Although others have shown that N-terminally GFP-tagged Vps74 localizes to Golgi-like puncta, a more robust test of the functional consequences of fusing a fluorescent protein to Vps74 is needed.8 ,11 For this purpose, we generated three mNeon-tagged forms of Vps74 (Figure 1A) and used a yeast strain lacking VPS74 and TED1 balanced with a counter-selectable copy of TED1 on a plasmid (pTED1(URA3) to assess whether they were functional. TED1 encodes a remodelase that removes phosphoethanolamine from mannose 2 of glycosylphosphatidylinositol-anchored proteins (GPI-AP) in the ER, an essential function that is shared by Dcr2, which acts in the Golgi.26 Dcr2 is a Vps74 client, and thus cells lacking VPS74 and TED1 are not viable because Dcr2 is mislocalized and degraded in the vacuole.26 Therefore, whether a particular variant can support the growth of cells lacking VPS74 and TED1, reflects the variant’s impact on the Golgi retention of Dcr2.26 All three mNeon/Vps74 fusion proteins were functional, as assessed by their ability to complement the synthetic lethal growth phenotype of cells lacking the VPS74 and TED1 genes26 (Figure 1B). Similarly, vps74Δ ted1Δ cells expressing the mNeon/Vps74 fusion proteins grew like control cells at 37°C (Figure 1C). Although the expression levels of Vps74, Vps74-mNeon, and mNeon-Vps74 were similar (Figure 1D), none of the Vps74/mNeon constructs were as effective as WT Vps74 in maintaining the steady-state levels of Dcr2 (Figure 1E). However, in the case of Mnn5 and Kre2, mNeon-Vps74 was more effective in the retention of these clients than Vps74-mNeon (Figure 1F).9 ,27 Interestingly, the tandem chimera (Vps74-mNeon-Vps74) was no more effective than its monomeric counterparts in the retention of Dcr2, Mnn5, and Kre2 (Figures 1E and 1F) suggesting that tethering two molecules of Vps74 did not increase the effectiveness of the adaptor.
Figure 1.
Vps74/mNeon fusion proteins are functional
(A) Schematic representations of the various Vps74/mNeon fusion proteins used in this study.
(B) VPS74-mNeon, mNeon-VPS74, and VPS74-mNeon-VPS74 can support the growth of the synthetic deletion mutant vps74Δ ted1Δ. 10-fold serial dilutions of the indicated yeast strains were spotted onto plates and thereafter incubated as indicated. n = 3.
(C) vps74Δ ted1Δ cells expressing the various Vps74/mNeon fusion proteins are not temperature-sensitive for growth. 10-fold serial dilutions of the indicated yeast strains were spotted onto plates and thereafter incubated as indicated. n = 3.
(D) Immunoblot and quantification of the steady-state levels of the various Vps74/mNeon fusion proteins in vps74Δ ted1Δ cells. Pgk1 serves as a gel load control. n = 3.
(E) Immunoblots and quantification of steady-state levels of Dcr2 in vps74Δ cells expressing the various Vps74/mNeon fusion proteins. Pgk1 serves as a gel load control. n = 4.
(F) Immunoblots and quantification of the steady-state levels of Mnn5 and Kre2 in cells expressing the various Vps74/mNeon fusion proteins. Pgk1 serves as a gel load control. n = 3.
Data are presented as mean ± SD and each data point represents a biological replicate. Statistical analyses were performed using one-way ANOVA followed by Dunnett’s multiple comparisons test (D) or Tukey’s multiple comparisons tests (E and F).
To establish the extent to which the three tagged forms of Vps74 could bind to different Golgi cisternae, we integrated the various mNeon-tagged variants at the VPS74 locus in cells expressing mCherry-Sed5 (a cis Golgi resident), Sec21-mScarlet (a cis, medial, and trans Golgi resident) or Sec7-mScarlet (a trans Golgi resident) (Figure 2A). Vps74-mNeon showed the fewest puncta ∼5 puncta per 20 cells, whereas mNeon-Vps74 and Vps74-mNeon-Vps74 showed roughly the same number of puncta per cell (∼35–40 per 20 cells) (Figure 2B). Despite the reduction in total puncta, the distribution of Vps74-mNeon across Golgi cisternae, as judged by colocalization with Sed5, Sec21, and Sec7, was like that seen with mNeon-Vps74 and Vps74-mNeon-Vps74 (Figure 2C). These fluorescence data indicate that Vps74 localizes to cis, medial, and trans cisternae. The relative decrease in Vps74-mNeon Golgi puncta is in accord with our findings that cells expressing this version of the adaptor show a reduction in the steady-state levels of Dcr2, Mnn5, and Kre2 (Figures 1E and 1F). We conclude that Vps74-mNeon is functional but hypomorphic due to the protein’s reduced capacity to bind to Golgi membranes. Importantly, the recruitment of Vps74 to multiple cisternae correlates well with the distribution of the adaptor’s clients in cells.27 ,28
Figure 2.
Vps74/mNeon fusion proteins do not differ in their Golgi cisternae distributions
(A) Co-localization of the various Vps74/mNeon proteins in cells expressing mCherry-Sed5 (cis), Sec21-mScarlet (cis, medial and trans) or Sec7-mScarlet (trans) Golgi residents. Scale bars, 5 μm. n = 3.
(B) Quantification of the number of mNeon puncta from experiments depicted in (A).
(C) Quantification of the co-localization data for the various Vps74/mNeon proteins with cis, medial and trans Golgi markers from experiments depicted in (A).
Data are presented as mean ± SD and each data point represents a biological replicate. Statistical analyses were performed using two-way ANOVA followed by Tukey’s multiple comparisons tests (B and C).
The co-localization data presented in Figures 2A–2C showed that the three Vps74 mNeon fusion proteins colocalize with ∼40%–45% of Sed5 (cis Golgi) positive puncta, with ∼30%–35% of Sec7 (trans Golgi) positive puncta and with ∼75%–90% of Sec21 (cis, medial, and trans). These findings reveal that irrespective of the positioning of mNeon on Vps74 all three variants display similar Golgi distributions. Apparently, Vps74 can bind to membranes with lower steady-state levels of PI4P than found in the trans Golgi, implying that an additional/alternative mechanism may account for the protein’s localization to cis and medial cisternae.20 ,21
Client over-expression is sufficient to recruit Vps74 to Golgi membranes
To explore the prospect of an additional membrane-binding mechanism, we asked if Vps74 could be recruited to the Golgi directly by binding to its clients. To address this, we introduced high copy number plasmids containing various client genes into cells expressing Vps74-mNeon as their sole source of the adaptor. We chose Vps74-mNeon for these experiments as the fusion protein, while being functional (Figure 1), was found on fewer Golgi puncta, making any increase more readily apparent. We selected a subset of Vps74 clients to test as well as the non-Vps74 client OCH1.27 The data presented in Figure 3A reveal that when transformed with high copy number plasmids containing the client genes MNN5, KRE2,9 ,27 and GRX7, cells had a larger number of Vps74-mNeon puncta than those containing empty vector or the non-Vps74 client OCH1 plasmid. On average, the presence of high copy number plasmids expressing client genes increased puncta to ∼20 per 20 cells (or 4-fold) compared to the non-client containing plasmid or vector only which showed ∼5 puncta per 20 cells (Figure 3A). The steady-state levels of Grx7, Mnn5, Kre2, and Och1 were indeed increased (∼5- to 10-fold) relative to wildtype cells as judged by immunoblots of whole cell extracts from cells transformed with the high copy number plasmids in which clients (excluding Kre2) were expressed as C-terminal fusion proteins to 9 copies of the myc epitope tag (Figure S1A). The addition of an epitope tag to these clients did not affect the capacity of over-expressed clients to increase the number of Vps74-mNeon puncta (Figure S1B). By contrast, overexpression of clients in cells expressing mNeon-Vps74 did not show any statistically significant increase in the number of puncta observed (Figure S1C). Nor did client overexpression alter the steady-state levels of Vps74 (Figure 3B).
Figure 3.
Over-expression of clients is sufficient to recruit Vps74 to Golgi membranes
(A) Cells expressing GRX7, MNN5 and KRE2 from high copy number plasmids show more Golgi puncta. Scale bars, 5 μm. n = 9.
(B) Over-expression of clients does not alter the steady-state levels of Vps74. Lefthand side immunoblot from one biological replicate. Righthand side quantification data from 4 biological replicates (n = 4).
(C) GRX7 is a dosage suppressor of the temperature-sensitive growth phenotype of vps74-1 ted1Δ cells. 10-fold serial dilutions of the indicated yeast strains were spotted onto plates and thereafter incubated as indicated. n = 3.
(D) The steady-state level of Grx7 is reduced in cells lacking VPS74. n = 3.
Data are presented as mean ± SD and each data point represents a biological replicate. Statistical analyses were performed using one-way ANOVA followed by Dunnett’s multiple comparisons tests (A and B) or two-tailed unpaired t test (D).
We recovered GRX7 as a dosage suppressor of the temperature-sensitivity of vps74-1 ted1Δ cells (Figure 3C), and like other clients, in the absence of VPS74 the steady-state levels of Grx7 were reduced (∼20% of endogenous levels) (Figure 3D). Grx7 is a type II integral membrane protein with a short cytoplasmic N-terminal region and reportedly functions as a Golgi-localized monothiol glutaredoxin.29
Possible explanations for the observed increase in puncta in cells overexpressing Grx7, Mnn5, and Kre2 include alterations to the steady-state distributions of these proteins, whereby they are found in more distal and PI4P-enriched cisternae. Alternatively, Vps74 can be recruited to the Golgi by binding directly to the N-termini of its clients. To address these scenarios, we introduced the high copy number GRX7, MNN5, and KRE2 containing plasmids into cells expressing Vps74-mNeon, and either mCherry-Sed5, Sec21-mScarlet, or Sec7-mScarlet, and quantified the number of co-localizing puncta (Figure 4A). These experiments revealed that over-expression of individual clients did not alter the overall percentage of Vps74-mNeon puncta in cisternae fluorescently labeled with Sed5, Sec21, or Sec7 when compared to cells transformed with empty vector only (Figures 4A and 4B). To conclude, clients can play a direct role in the recruitment of Vps74 to Golgi cisternae.
Figure 4.
Overexpression of clients does not alter the cisternal distribution of Vps74
(A) Over-expression of GRX7, MNN5, and KRE2 is sufficient to recruit Vps74-mNeon to cis, medial, and trans Golgi cisternae. Scale bars, 5 μm. n = 3.
(B) Client over-expression does not significantly alter the distribution of Vps74 across Golgi cisternae.
Data are presented as mean ± SD and each data point represents a biological replicate. Statistical analyses were performed using two-way ANOVA followed by Sidak’s multiple comparisons test.
Client over-expression is not sufficient to recruit the PI4P-binding deficient and β hairpin variants of Vps74 to the Golgi
Previous studies identified a role for PI4P and the β hairpin in the recruitment of Vps74 to Golgi membranes.20 Considering the findings presented in Figures 3 and 4, we re-examined the role of these features in the recruitment of Vps74 to the Golgi by generating amino acid substitutions to the PI4P binding site at W88, R97 and K178, R181, and deleting the amino acids comprising the β hairpin (amino acids 197–208 (Δ197-208)).20 The functional consequences of these variants were assessed in cells lacking VPS74 and TED1 (Figure 5A). Only the R97A variant of Vps74 was incapable of supporting the growth of vps74Δ ted1Δ cells (Figure 5A). Surprisingly, substitutions at three of the four amino acids previously reported to be important for Vps74 binding to PI4P (W88, K178, and R181) did not result in loss of function of the protein, nor were vps74Δ ted1Δ cells expressing these variants (W88A and K178A R181A) temperature-sensitive for growth (Figure 5B). Although vps74Δ ted1Δ cells expressing the β hairpin deletion variant Vps74 (Δ197-208) were viable at 25°C, these cells were temperature-sensitive for growth at 37°C (Figure 5B). The β hairpin deletion variant also conferred calcofluor white sensitivity to cells (a proxy for glycosylation defects),30 whereas vps74Δ ted1Δ cells expressing the W88A and K178A R181A amino acid substitution variants of Vps74 were no more sensitive to calcofluor white, than cells expressing the wildtype protein (Figure 5B). It appears that the β hairpin does not play a crucial role in the Golgi membrane recruitment of Vps74 when cells are grown at 25°C.
Figure 5.
Amino acid substitutions to the PI4P-binding site and deletion of the β hairpin of Vps74 impact client-binding in vivo and in vitro
(A) The R97 variant of Vps74 cannot support the growth of vps74Δ ted1Δ cells. 10-fold serial dilutions of the indicated yeast strains were spotted onto plates and thereafter incubated as indicated. n = 3.
(B) Expression of the β hairpin deletion variant confers temperature-sensitivity for growth and calcofluor sensitivity in vps74Δ ted1Δ cells. 10-fold serial dilutions of the indicated yeast strains were spotted onto plates and thereafter incubated as indicated. n = 3.
(C) Immunoblots and quantification of the steady-state levels of clients in vps74Δ cells expressing the Vps74 variants. Pgk1 serves as a gel load control. n = 6.
(D) The R97, K178 R181, or β hairpin deletion (Δ197-208) variants show reduced binding to the N-terminus of Mnn4 in an in vitro mixing assay. Upper panel representative immunoblot, lower panel quantification from four biological replicates (n = 4).
(E) Over-expression of Kre2 is not sufficient to recruit the R97, K178 R181, or β hairpin deletion (Δ197-208) variants to Golgi membranes. Scale bars, 5 μm. n = 3.
(F) A heatmap depicting the impact of the Vps74 variants on client retention. Note that the steady-state levels of clients in cells lacking VPS74 (Empty vector, C) have been subtracted.
Data are presented as mean ± SD and each data point represents a biological replicate. Statistical analyses were performed using one-way ANOVA followed by Tukey’s multiple comparisons test (C) or Dunnett’s multiple comparisons test (D), or two-way ANOVA followed by Tukey’s multiple comparisons test (E).
An important caveat in the interpretation of these findings is the genetic background (vps74Δ ted1Δ) used to assess the function of the various amino acid variants. Cells lacking VPS74 and TED1 are not viable because Dcr2 (a Vps74 client) is mislocalized and degraded in the vacuole.26 In line with this reasoning, the steady-state levels of Dcr2 were significantly reduced in the R97A, K178A R181A and β hairpin (Δ197-208) variants, comparable to those observed in cells lacking VPS74 (Figure 5C). We note that the steady-state levels of the Vps74 variants are increased when TED1 is deleted (Figure S2A). However, the increased levels of the K178A, R181A, and β hairpin variant proteins only resulted in a modest increase in the steady-state levels of Dcr2 (Figure S2A). Presumably, the essential activity of Dcr2 can be provided by ∼ 30% of endogenous levels of the enzyme (Figure S2A). Nevertheless, these findings were recapitulated in in vitro mixing experiments using the Mnn4 N-terminus (Figure 5D) and revealed a direct role for the β hairpin and R97 (in the PI4P binding site) in client-binding. Thus, in addition to the reported importance of the β hairpin in Golgi membrane-binding21 it also appears to play a key role in Vps74 client-binding, at least in the case of Mnn4.
To further interrogate the impact of the W88, R97, K178, R181, and β hairpin variants on Vps74 membrane binding, we asked whether over-expression of Kre2 (Figures 3A and S2B) was sufficient to recruit these adaptor variants to Golgi membranes (Figure 5E). However, puncta were only apparent in cells expressing wildtype VPS74, and to a lesser extent in cells expressing the W88A substitution variant (Figure 5E). These findings were recapitulated when Grx7-9myc was overexpressed, except for the W88A variant, which had a greater effect on Grx7 retention than on Kre2 retention (Figures 5E, S2C, and S2D).
To explore the extent to which the Vps74 variants affected the retention of clients in the Golgi, we examined the steady-state levels of Kre2, Mnn4, Mnn2, Grx7, and Mnn5 in variant-expressing cells (Figures 5C and 5F). These experiments revealed that substitutions to W88 and K178, R181 had a comparatively minimal impact on the steady-state levels of clients, whereas the R97 and the β hairpin variants had the largest effect on client retention (Figures 5C and 5F). Although amino acid substitutions at R97, W88, and K178, R181 reportedly resulted in mislocalization of Kre2 to the vacuole,20 these variants of Vps74 (with the exception of the R97 variant, which was not tested) were not sensitive to calcofluor white (Figure 5B) unlike cells lacking the KRE2,9 nor did cells expressing the W88 and K187, R181 variants show a precipitous reduction in the steady-state levels of Kre2 (Figures 5C and 5F).
Our results on substitutions to R97, W88, and K178, R181 are difficult to reconcile with a critical role for PI4P recruiting Vps74 to Golgi membranes. Except for Grx7, the W88 variant had a comparatively modest effect on Vps74 client retention (Figures 5C and 5F). Similarly, except for Dcr2 and Grx7, the K178A, R181A variant had a comparatively modest effect on all other clients tested (Figures 5C and 5F). However, as a structure of Vps74 bound to PI4P is not available, we cannot exclude the possibility that other amino acids in addition to R97 might also be critical for Vps74-PI4P binding in cells. Nevertheless, R97 and the β hairpin appear to play a role in adaptor-client-binding, as judged by in vitro binding studies with the N-terminus of Mnn4 (Figure 5D).
PI4P binding may be a co-requisite for recruitment of Vps74 to Golgi membranes
To further assess whether recruitment of Vps74 to PI4P-enriched Golgi cisternae was critical for client retention, we generated a dimer of Vps74 in which the PH domain of FAPP1, which has been shown to bind to PI4P in yeast cells and to co-localize with the trans Golgi protein Sec7,31 ,32 was inserted between the two monomers (Figure 6A). We opted for tethering two molecules of Vps74 as a covalent dimer is functional (Figures 1B and 1C). The W88A, R97A, and K178A, R181A substitutions and β hairpin deletion variants were introduced into both Vps74 monomers (Figure 6A) and were expressed from the VPS74 locus. In cells expressing Vps74-mNeon-Vps74 and the vps74-mNeon-vps74 variants, only WT Vps74-mNeon-Vps74 and the W88A vps74-mNeon-vps74 variant showed any puncta (Figure 6B), in agreement with our observations with Vps74-mNeon and these variants (Figure 5E). By contrast, WT Vps74-mNeon-PH-Vps74 and all the vps74-mNeon-PH-vps74 variants showed puncta, consistent with the ability of the FAPP1 PH domain to bind PI4P in yeast cells (Figure 6B).31 However, when we examined the steady-state levels of two clients (Mnn5 and Kre2) in cells expressing the Vps74-mNeon-Vps74 or Vps74-mNeon-PH-Vps74 variants R97A, K178A, R181A, and Δ197-208 (the β hairpin deletion), the Vps74-mNeon-PH-Vps74 variants were no better than the Vps74-mNeon-Vps74 variants in restoring the steady-state levels of Mnn5 or Kre2 (Figure 6C). Interestingly, both the WT and W88 variant of Vps74-mNeon-PH-Vps74 were less effective in maintaining the steady-state levels of Mnn5 than their Vps74-mNeon-Vps74 counterparts, suggesting that when the adaptor was localized to more trans cisternae PI4P enriched cisternae, it was less efficient retaining this client in the Golgi (Figure 6C). Similar findings were also obtained for Mnn4 and Mnn2 (Figure S3).
Figure 6.
PI4P binding may be a co-requisite for recruitment of Vps74 to Golgi membranes
(A) Depiction of constructs used in B and C.
(B) Inserting the PH domain of FAPP1 into Vps74-mNeon-Vps74 is sufficient to recruit Vps74 variants to the Golgi. Scale bars, 5 μm. n = 3.
(C) The R97, K178 R181 and β hairpin variants of Vps74-mNeon-PH-Vps74 do not restore the steady-state levels of Mnn5 or Kre2. Pgk1 serves as a gel load control. n = 3.
(D) A time course of Pik1 degron-mediated depletion reveals a role for PI4P and clients in the recruitment of Vps74 to Golgi membranes. Lefthand side depicts the experimental paradigm for degron-mediated degradation of Pik1. Righthand side summary of the time course data for 3 biological replicates: loss of Vps74 Golgi puncta, degradation of Pik1, and the steady-state levels of mNeon-Vps74.
Data are presented as mean ± SD and each data point represents a biological replicate. Statistical analyses were performed using two-way ANOVA followed by Tukey’s multiple comparisons tests (B and C).
To obtain more insight into the role of PI4P in Vps74 membrane recruitment we examined the fate of mNeon-Vps74 membrane association in cells in which Pik1 (the sole yeast Golgi PI4P kinase33) was subject to auxin-inducible proteosomal degradation.34 We generated a yeast strain in which the mAID2 degron34 coding region appended with two HA tags was fused in frame to the N-terminal coding sequence of the PIK1 gene at the PIK1 locus and OsTIR1(F74G) was integrated at the GAL1 locus. This strain (in which mNeon-Vps74 was expressed at the VPS74 locus, and mCherry-SED5 was expressed from the SED5 locus) was then transformed with a high copy number plasmid with or without KRE2 (KRE2 2μ). We chose mNeon-Vps74 in this instance because we wished to observe a decrease in puncta overtime rather than an increase. When these strains were grown in media containing galactose and in the presence of the TIR1(F74G) ligand 5-Ph-IAA, mAID-HA-Pik1 is targeted for degradation by the proteosome.34 These strains allowed us to monitor the steady-state levels of Pik1 and mNeon-Vps74 over the time course of experiments (by immunoblotting) as well as visualize mCherry-Sed5 (as a proxy for Golgi morphology) and visualize and quantify the number of mNeon-Vps74 puncta present (as a proxy for PI4P levels). We examined 3 time points under galactose induction conditions (0, 90, and 120 min). Representative fluorescence microscopy images are given in Figure S4A. Quantification and bar graphs of Vps74 puncta number, protein levels of mAID-HA-Pik1 and mNeon-Vps74 and a representative immunoblot (from 1 of the three replicates) are presented in the Figures S4B and S4C, respectively, while three graphs summarizing data from these experiments are presented in Figure 6D.
The steady-state levels of mNeon-Vps74 were not statistically different across the duration of the experimental time course. In contrast, the steady-state levels of mAID-HA-Pik1 declined over the 120 min duration of 5-Ph-IAA treatment reaching ∼50% of time 0 levels at 90 min and ∼30% of time 0 levels at 120 min. The rate of decline in the strains carrying the empty vector (empty vector + 1 mM 5-Ph-IAA) or KRE2 (KRE2 2μ + 1 mM 5-Ph-IAA) were indistinguishable. This system is a little leaky as evidenced by the modest decline in steady-state levels of mAID-HA-Pik1 in controls (Figures 6D, S4B, and S4C).
At t = 0 min the number of mNeon-Vps74 puncta present in the empty vector + 1 mM 5-Ph-IAA and KRE2 2μ + 1 mM 5-Ph-IAA strains was not significantly different. However, over the course of the first 90 min the rate of decline in puncta number was greater for empty vector + 1 mM 5-Ph-IAA as indicated by the slope. In addition, the absolute number of puncta present in empty vector + 1 mM 5-Ph-IAA cells (∼5/per 20 cells) was significantly lower than in KRE2 2μ + 1 mM 5-Ph-IAA cells (∼20/per 20 cells). However, between 90 and 120 min the rate of loss of puncta is dramatically increased in KRE2 2μ + 1 mM 5-Ph-IAA cells, as was the absolute number of puncta—which was now not statistically significantly different from those seen in empty vector + 1 mM 5-Ph-IAA cells. These data confirm an important role of PI4P in the recruitment of Vps74 to Golgi membranes but are also consistent with a role for client N-termini in Vps74 membrane binding in agreement with the data presented in Figures 3A, 4A, 4B, S2B, and S2C.
To conclude, our findings are consistent with the role for clients and PI4P in the association of Vps74 with Golgi membranes, while also revealing that one or more of the amino acids previously identified as being required for PI4P binding (R97 and K178, R181) are in fact part of the client-binding site.
The client-binding site on Vps74 includes two evolutionarily conserved adjacent loops
The prospect that the amino acid residues important for PI4P binding and the β hairpin might constitute part of the client-binding site on Vps74, prompted us to search for evolutionarily conserved, surface exposed and membrane opposing regions on Vps74 and human GOLPH3s. This analysis identified two regions on Vps74/GOLPH3s defined by amino acids 78–90 and 165–177 (Vps74 numbering) (Figure 7A). These residues define two loops on Vps74 (hereafter referred to as Loop1 and Loop2) that flank the PI4P binding site and the β hairpin (Figures 7A and 7C). To identify those amino acids critical for client-binding, we used AlphaFold2. For these analyses we used the amino acid sequences of 9 client N-termini (Figure S5A) and evaluated possible interactions of these clients with Vps74 from the AlphaFold2 predictions. This in silico analysis identified W88 and D90 in Loop1 and E166, W168 and Q176 in Loop2 as the most frequent presumptive contact sites between clients and Vps74 (Figure 7B).
Figure 7.
The client-binding site on Vps74 is located in two adjacent loops
(A) The GOLPH3s share two conserved, surface exposed flexible loops located on the membrane-proximal surface. Note that Loop1 and Loop2 are adjacent to the PI4P binding site.
(B) Docking client N-termini to Vps74 with AlphaFold2 identifies frequent contact sites in the client-binding adaptor interface.
(C) A structural rendering of Vps74 in which the locations of Loop1 and Loop2 are shown relative to the Golgi membrane surface. Amino acids targeted for substitution are indicated along with depictions of their respective side chains.
(D) Immunoblots and quantification of steady-state levels of clients in vps74Δ cells expressing the Loop1, Loop2, Loop1+Loop2 and W88 variants. Pgk1 serves as a gel load control. n = 6.
(E) A heatmap summarizing the impact of the Vps74 Loop1 and Loop2 variants on client retention. Note that the steady-state levels of clients in cells lacking VPS74 (Empty vector, D) have been subtracted.
(F) The impact of the Loop1 and Loop2 variants on Mnn4 binding to Vps74 are recapitulated in an in vitro mixing assay. n = 6.
Data are presented as mean ± SD and each data point represents a biological replicate. Statistical analyses were performed using one-way ANOVA followed by Tukey’s multiple comparisons tests (D and F).
To examine the impact of substitutions in Loop1 and Loop2 on Vps74’s adaptor function, we generated three substitution variants that encompassed F87, W88, N89, D90 and E166, T167, W168 either singularly or in combination. Variant function was assessed in cells lacking VPS74 and TED1 and carrying a counter-selectable copy of the TED1 gene on a plasmid (Figures S5B and S5C). Of the three Vps74 amino acid substitution variants examined (87AAAA90, 166AAA168, 87AAAA90 + 166AAA168), cells expressing 166AAA168 or 87AAAA90 + 166AAA168 were unable to support the growth of vps74Δ ted1Δ cells (Figure S5B). Cells expressing 87AAAA90 grew indistinguishably from wildtype and were not temperature-sensitive for growth or sensitive to calcofluor white treatment (Figure S5C). We next expressed these three variants, as well as the W88A variant, in cells lacking VPS74, and examined the steady-state levels of Mnn5, Kre2, Mnn4, Mnn2, Dcr2, and Grx7 by immunoblotting (Figure 7D). Quantification of these data revealed that the combined substitutions to Loop1 and Loop2 (87AAAA90 + 166AAA168) had the most significant impact on the steady-state levels of all clients tested, while W88A was the least impactful (Figures 5C, 5F, 7D, and 7E). The identification of W88 as a presumptive client-binding residue is puzzling but likely reflects the relative robustness of our in-silico method. Based on the experiments conducted herein, W88 is unlikely to be imperative for PI4P- or client-binding.
In agreement with our genetic assessment, in cells expressing the loss of function Loop2 variant 166AAA168 (Figure S5B), the steady-state level of Dcr2 was substantially reduced (Figure 7D), whereas for the other clients examined the steady-state levels of Mnn4 and Mnn2 were affected to the greatest extent by these amino acid substitutions (Figures 7D and 7E). In contrast, the steady-state levels of Mnn5 were largely unaffected by amino acid substitutions to Loop2 whereas Kre2 retention was most significantly impacted by substitutions to Loop2 (Figures 7D and 7E). The effect of the combined Loop1+Loop2 substitutions appears to be additive, as cells expressing this variant showed a greater reduction in client steady-state levels than cells expressing either the Loop1 or Loop2 variants singularly (Figures 7D and 7E). The findings on Mnn4 steady-state levels in the various Vps74 variants could be replicated in an in vitro binding assay, using bacterially expressed Vps74 and the N-terminus of Mnn4 (Figure 7F).
In sum, these studies define the client-binding site on Vps74 and reveal that not all clients are similarly affected by amino acid substitutions at Loop1 and Loop2 (Figure 7E). The variable effect of Loop1 and Loop2 amino acid substitutions on client retention may explain in part how Vps74 (and other GOLPH3s) can accommodate client N-termini of differing amino acid composition and lengths (Figure S5A).7 ,9 ,10 ,27
A nanobody against Vps74 corroborates identification of the client-binding site
In an orthogonal approach to our use of amino acid substitutions to define the client-binding site, we isolated a suite of Vps74-binding nanobodies (Table S4).35 Plasmids expressing N-terminally ubiquitin-tagged nanobodies were introduced into yeast cells carrying a deletion of TED1 and a counter-selectable copy of TED1 linked to the URA3 gene (Figures S6A and S6B). Fusion to ubiquitin was necessary to increase the expression of nanobodies in the cytoplasm, however, endogenous cytoplasmic deubiquitinases cleaved ubiquitin, preserving the N-terminal sequence of the nanobody (Figure S6C). In this assay, cells expressing a nanobody that blocked an essential property on Vps74 would not be able to grow in ted1Δ cells as neutralization of Vps74 activity would phenocopy ted1Δ vps74Δ cells (Figure S6B). We chose one such inhibitory nanobody termed Vps74InNb#4 for further characterization (Figure 8A), as it also bound to human GOLPH3 and GOLPH3L, reasoning that it might bind to an evolutionarily conserved and therefore functionally significant region on the GOLPH3s (Figure 8B).
Figure 8.
The nanobody Vps74InNb#4 corroborates identification of the client-binding site on Vps74
(A) Expression of nanobody Vps74InNb#4 inhibits the growth of cells lacking TED1. 10-fold serial dilutions of the indicated yeast strains were spotted onto plates and thereafter incubated as indicated. n = 3.
(B) Vps74InNb#4 binds to Vps74, human GOLPH3 and GOLPH3L. n = 3.
(C) Expression of Vps74InNb#4 in wildtype cells reduces the steady-state levels of Mnn5, Kre2 and Dcr2. Pgk1 serves as a gel load control. n = 3.
(D) Vps74InNb#4 reduces the binding of the N-terminus of Mnn4 to Vps74 in vitro. n = 3.
(E) Expression of Vps74InNb#4 in wildtype cells blocks Golgi membrane recruitment of Vps74. Scale bars, 5 μm. n = 3.
(F) Vps74InNb#4 binds to Loop1 and the β hairpin of Vps74. Vps74InNb#4 was docked with Vps74 using AlphaFold3.
(G) Validation of the binding interface for Vps74InNb#4 on Vps74 with site-directed variants of Vps74.
Data are presented as mean ± SD and each data point represents a biological replicate. Statistical analyses were performed using one-way ANOVA followed by Tukey’s multiple comparisons test (C) or two-tailed unpaired t tests (C and D).
In agreement with its dominant negative effect in ted1Δ cells, when Vps74InNb#4 was expressed in wildtype cells, the steady-state levels of clients were significantly reduced as judged by immunoblots for Dcr2, Mnn5, and Kre2 (Figure 8C). This was not a result of changes in the steady-state levels of Vps74 (Figure 8C). The reduction of steady-state levels of Dcr2, Mnn5, and Kre2 was a direct result of Vps74InNb#4 binding to Vps74 (Figure S6C). Vps74InNb#4 also reduced the association of Mnn4 with Vps74 in an in vitro mixing assay (Figure 8D). Thus, Vps74InNb#4 likely binds to a membrane opposing surface on Vps74, a property that also blocked the binding of Vps74 to Golgi membranes (Figure 8E) and resulted in the mislocalization of clients to the vacuole (Figure S6D).
To validate that Vps74InNb#4 occupied the client-binding site, we docked the nanobody with Vps74 using AlphaFold3 (Figure 8F) and verified the interaction interface on Vps74 using site-directed variants in an in vitro mixing assay (Figures 8G and S6E). To conclude, Vps74InNb#4 bound to the β hairpin and to Loop1, but not to Loop2. Nevertheless, the interaction of Vps74InNb#4 with Vps74 was sufficient to prevent the adaptor from binding to Golgi membranes, and directly to Mnn4 in in vitro mixing experiments (Figures 8D and 8E). These data corroborate our interrogation of Loop1 and Loop2 by site directed mutagenesis (Figure 7).
The Arf1-GTP and Sac1 binding sites overlap with and exclude client-binding to Vps74
Vps74 has been shown to bind to the PI4P phosphatase Sac1, whereupon Vps74 reportedly stimulates the enzyme’s activity.21 ,22 Critically, the binding site on Vps74 for Sac1 encompasses Loop221 coinciding with part of the client-binding site we identify in this study (Figure 7). We have previously shown that Vps74 binds to the small GTPase Arf1 in its GTP-bound state.15 Unlike the Vps74-Sac1 association, the location of the Arf1-GTP binding site on Vps74 and the functional significance of this interaction has remained elusive. Nonetheless, Vps74/GOLPH3 binds to the Golgi vesicle coat complex coatomer14 ,15 and Arf1-GTP is critical for COPI vesicle formation.36 These findings are consistent with a role for Arf-GTP in the incorporation of Vps74 and its clients into COPI coated vesicles.
We took advantage of the availability of Vps74InNb#4 to investigate the relationship between Vps74, and its binding partners—Sac1 and Arf1-GTP. In in vitro mixing experiments Sac1 reduced Mnn4 binding to Vps74 by ∼ 85% (Figure 9A). These results concur with the data presented in Figure S7A, where we show that substitutions in Loop2, but not Loop1, reduce the binding of Sac1 to Vps74 in an in vitro mixing assay. These findings were corroborated with Vps74InNb#4, which preferentially binds to the β hairpin and Loop1 residues (Figures 8F, 8G, and 9B). Thus, when Vps74 is bound to Sac1, the adaptors capacity to bind its clients is reduced.
Figure 9.
Client, Arf1, and Sac1 binding sites overlap on Vps74
(A) Sac1 competes with Mnn4 for binding to Vps74. n = 3.
(B) Vps74InNb#4 does not block Sac1 binding to Vps74. n = 3.
(C) Sac1 competes with Arf1-GTP for binding to Vps74. n = 3.
(D) Vps74InNb#4 blocks binding of Arf1-GTP to Vps74. n = 5.
(E) Arf1-GTP competes with Mnn4 for binding to Vps74.
(F) The location of the client, Sac1 and Arf1-GTP binding sites on Vps74.
Data are presented as mean ± SD and each data point represents a biological replicate. Statistical analyses were performed using two-tailed unpaired t tests (A, B, C, and D).
Interestingly, the binding site on Vps74 for Arf1-GTP and Sac1 also overlap. Sac1 binding to Vps74 resulted in a ∼80% reduction in the binding of Arf1-GTP (Figure 9C). Overlapping binding sites for Sac1 and Arf1-GTP were validated using site directed mutants of Vps74 in in vitro mixing experiments (Figures S7A and S7B). In contrast to Sac1, Vps74InNb#4 blocked Arf1-GTP binding to Vps74 (Figure 9D). This finding agrees with the AlphaFold3 predicted structure of Vps74InNb#4 bound to Vps74, which revealed that the nanobody binds to Loop1 and the β hairpin (Figures 8F and 8G), and with the in vitro mixing experiments where increasing amounts of the Mnn4 N-terminus reduced Arf1-GTP binding to Vps74 (Figure 9E).
To conclude, the data presented in Figures 9 and S7 indicate that the binding sites for clients, Sac1 and Arf1 overlap with one another (Figure 9F). While we have not measured the KD for Sac1, Arf1-GTP or clients on Vps74, the in vitro mixing data we present here is consistent with Sac1 binding more robustly to Vps74 in cells than either Arf1-GTP or client N-termini. However, the extent to which Sac1 interferes with client and Arf1-GTP binding to Vps74 may be negligible under normal growth conditions, as Sac1 is predominantly an ER resident,31 ,32 whereas Vps74 is found on the Golgi membranes and in the cytoplasm—as is also the case of Arf1. Reportedly, Sac1 is found in the Golgi in cells deprived of glucose, rather than the ER.31 It is therefore possible that interactions between Sac1 and Vps74 are primarily restricted to changes in the cell’s growth parameters, such as when environmental glucose levels become limiting. The finding that Arf1-GTP and client-binding are exclusive of one another is difficult to reconcile with a role for Arf1-GFP in facilitating client selection by Vps74. Rather, Arf1-GTP may function to prevent client-free adaptors from being incorporated into nascent COPI vesicles upon hydrolysis of GTP.
Discussion
We report the identification of a single membrane opposing surface that mediates the binding of clients, Sac1 and Arf1-GTP to the Golgi adaptor protein yGOLPH3-Vps74. This binding site is comprised of evolutionarily conserved residues that encompass two loops (designated Loop1 and Loop2), the PI4P binding site, and the β hairpin. These findings were corroborated using a nanobody (Vps74InNb#4) that binds to Loop1 and the β hairpin of Vps74 in in vitro binding studies using the Mnn4 N-terminus, Sac1 and Arf1-GTP. As such, we anticipate that the client-binding site we identify on Vps74 will likely play an equivalent role in GOLPH3 family proteins.
We examined the steady-state levels of six Vps74 clients, of which four are glycosyltransferases, one a monothiol glutaredoxin (Grx7) and one a GPI-AP remodelase (Dcr2). These client N-termini are varied in the amino acid sequence composition, length, and cisternal distribution. Our study reveals that clients can have differing requirements on the Vps74 binding interface. For example, the Golgi retention of Mnn4, Mnn2, and Dcr2 are particularly sensitive to amino acid substitutions in Loop2. While Mnn5 retention is particularly sensitive to amino acid substitutions in Loop1+Loop2 whereas Kre2 retention is largely unaffected by amino acid substitutions in Loop1 but was affected by substitutions to Loop2 or Loop1+Loop2 (Figure 7). These findings may help to reconcile how the GOLPH3 adaptor proteins can accommodate client N-termini of varying lengths and amino acid compositions.7 ,8 ,9 ,10
Our findings on the requirement for amino acids previously shown to be important for PI4P and membrane binding (via the β hairpin) are more difficult to interpret as client-binding can also contribute to Vps74 membrane-binding (Figures 3A, 4A, and 4B). Thus, loss of membrane association in vivo (by fluorescence microscopy) can no longer be used as a direct indication of a loss of PI4P-binding, or a loss of membrane binding via the β hairpin. Much of our data were obtained by examining the steady-state levels clients, it is therefore not possible to uncouple the effects of loss of Vps74 membrane association from direct loss of client-binding. Support for the PI4P-binding site in client-binding comes from examining the steady-state levels of clients in Vps74 K178A, R181A variant expressing cells. While the K178A, R181A variant had little impact on the steady-state levels of the glycosyltransferases examined (in vivo or in vitro), this variant did significantly reduce the steady-state levels of Dcr2 and Grx7 (Figures 5C and 5F) despite the amino acid sequences of their N-termini being quite divergent (Figure S5A). In line with the requirement of R97 to support the growth of vps74Δ ted1Δ cells (Figure 5A), client retention was universally affected by a substitution with Ala at this position (Figures 5C and 5F). This would be expected if this residue was critical for membrane-binding via PI4P. However, in vitro mixing experiments with Mnn4, revealed that R97 was important for Vps74-binding to this client (Figure 5D). Similarly, a critical role for the β hairpin in the membrane association of Vps74 is also unclear. Deletion of the β hairpin did not result in loss of function of Vps74 (Figure 5A), although cells expressing this variant were temperature-sensitive and calcofluor white sensitive (Figure 5B). Nevertheless, the β hairpin deletion variant of Vps74, like the R97 variant, had the greatest impact on the steady-state levels of all clients examined (Figures 5C and 5F). In addition, in in vitro mixing experiments with the Mnn4 N-terminus, recombinant Vps74 lacking the β hairpin was significantly compromised in its capacity to bind directly to this client (Figure 5D).
What has our study revealed about the role of PI4P in Vps74’s binding to Golgi membranes? Based on the findings reported herein it appears unlikely that PI4P is the only ligand for Vps74’s association with Golgi membranes as this can also be achieved by binding directly to clients. Our experiments using a mAID-mediated degradation of Pik1 are also consistent with a role for both clients and PI4P in the recruitment of Vps74 to the Golgi. For example, if PI4P was exclusively required for Vps74 to bind to Golgi membranes the rate of puncta loss should be the same for both empty vector + 1 mM 5-Ph-IAA cells and KRE2 2μ + 1 mM 5-Ph-IAA cells. This is not the case. There are at least two possible interpretations for the phenomenon observed for KRE2 2μ + 1 mM 5-Ph-IAA cells between 90 and 120 min. Firstly, that there was a precipitous drop in PI4P levels that resulted in dramatic changes to the integrity of the Golgi. However, this appears not to be the case, at least for the cis Golgi where Sed5p is localized as the morphology and number of puncta did not differ substantially from the 0 and 90- and 120-min time points (Figure S4A). Secondly, these data suggest that cooperative binding of PI4P and clients to Vps74 may increase the robustness of client-receptor interactions. The data obtained for the 120 min time point are consistent with a scenario that when depletion of PI4P levels below the threshold amount required for cooperative binding, Vps74 can no long bind as robustly to its clients. In any case our findings are nevertheless consistent with a role for clients in the direct recruitment of Vps74 to Golgi membranes.
To conclude, our findings with the PI4P and β hairpin variants are not consistent with a crucial or exclusive role for these regions of Vps74 in Golgi membrane-binding. Rather, it may be the case that they play a dual role—that includes client-binding and membrane-binding. The data we present herein do not allow us to distinguish between these two possibilities. Nor was it possible for us to ascertain whether PI4P-binding is a co-requisite for adaptor-client-binding. In addition, our amino acid substitution variants and in silico analysis did not allow us to distinguish the orientation of client N-termini on Vps74 (i.e., whether the N-terminus of a client is orientated toward Loop1 and the β hairpin, or toward Loop2). Lastly, the inhibitory nanobody Vps74InNb#4 corroborated our identification of the Mnn4-binding site on Vps74 (Figures 8D and 8F).
Our application of Vps74InNb#4 in in vitro mixing assays with Sac1, Arf1-GTP, and the Mnn4 N-terminus was instrumental in establishing that Mnn4 competes for binding to Vps74 with Sac1 and Arf1-GTP. This may also be the case for other clients more generally, but this will require the use of human GOLPH3s and their clients (for example), as these interactions appear to be more robust than between their yeast counterparts.7 ,8 ,9 ,10 Moreover, Sac1 and Arf1-GTP also compete with one another for binding to Vps74 suggesting that in cells these proteins may function in part to negatively regulate client/adaptor interactions. These findings were entirely unexpected. What then is the physiological significance of the binding of Arf1-GTP to Vps74? Our biochemical studies revealed that the binding-site for Arf1-GTP and clients overlap and compete with one another for binding to Vps74 (Figure 9E). Perhaps the association of Arf1-GTP with Vps74 serves to prevent futile incorporation of client-less adaptor into COPI coated vesicles as hydrolysis of GTP would release any Arf1-bound Vps74 from Golgi membranes.
Vps74InNb#4, the inhibitory nanobody against Vps74 that we identified in this study, allowed us to use wild-type proteins to explore client-binding sites and to define the overlapping binding sites on Vps74 for Sac1, Arf1, and clients. As Vps74InNb#4 also binds to human GOLPH3 and GOLPH3L (Figure 8B), this nanobody may be a useful reagent to counteract GOLPH3s′ activities in mammalian systems, particularly in cancer cells with GOLPH3 amplification.
Limitations of the study
Because of the low binding affinities, we could only perform in vitro binding studies with one client—Mnn4, an atypical Vps74 client with a much longer N-terminal sequence. Although mutations in the PI4P-binding site disrupted client binding in vivo and in vitro, we could not determine whether PI4P plays a role in the coincident detection of Vps74 clients.
Resource availability
Lead contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, David K. Banfield (bodkb@ust.hk).
Materials availability
All strains, plasmids and reagents used in this study are available from the lead contact upon request.
Data and code availability
-
•
Data reported in this paper will be shared by the lead contact upon request.
-
•
This paper does not report novel codes.
-
•
Any additional information required to reanalyze the data reported in this paper is available from the lead contact.
Acknowledgments
We thank the Biosciences Central Research Facility (BioCRF) at HKUST (Clear Water Bay) for the use of Zeiss LSM 980 Confocal Microscope, the ChemiDoc system and the Fast Protein Liquid Chromatography. This work was supported by grants from the Hong Kong Research Grants Council to D.K.B. (16102320, 16102722, and 16101624). Z.Y. was the recipient of a Hong Kong Ph.D. Fellowship.
Author contributions
Conceptualization, D.K.B.; methodology, A.M.L., Z.Y., and D.K.B.; validation, D.K.B.; investigation, A.M.L. and Z.Y.; writing – original draft, D.K.B.; writing – review and editing, A.M.L., Z.Y., and D.K.B.; visualization, A.M.L. and Z.Y.; supervision, D.K.B.; project administration, D.K.B.; funding acquisition, D.K.B.
Declaration of interests
The authors declare no competing interests.
STAR★Methods
Key resources table
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Antibodies | ||
| Mouse monoclonal anti-myc (dilution factor 1:1000) | Roche | Cat#11667149001; RRID: AB_390912 |
| Mouse monoclonal anti-HA (dilution factor 1:1000) | Roche | Cat#11583816001; RRID: AB_514505 |
| Mouse monoclonal anti-Pgk1 (dilution factor 1:10000) | Molecular Probes | Cat#459250; RRID: AB_2532235 |
| Rabbit polyclonal anti-Kre2 (dilution factor 1:500) | DKB lab collection | N/A |
| Rabbit polyclonal anti-GFP (dilution factor 1:4000) | Sigma | Cat#G1544; RRID: AB_439690 |
| Rabbit polyclonal anti-Vps74 (dilution factor 1:4000) | DKB lab collection | N/A |
| Rabbit polyclonal anti-Arf1 (dilution factor 1:2000) | DKB lab collection | N/A |
| Goat polyclonal anti-mouse IgG (dilution factor 1:3000) | Sigma | Cat#A8924; RRID: AB_258426 |
| Donkey polyclonal anti-rabbit IgG (dilution factor 1:3000) | GE healthcare | Cat#NA934; RRID: AB_772206 |
| Bacterial and virus strains | ||
| E. coli BL21(DE3) | Lab collection | N/A |
| Chemicals, peptides, and recombinant proteins | ||
| Fluorescent Brightener 28 (calcofluor white-CFW) | Sigma | Cat#F3543 |
| 5-Fluoroorotic acid (5-FOA) | Zymo Research | Cat#F9001-1 |
| Trichloroacetic acid (TCA) | Sigma | Cat#T8657 |
| Dithiothreitol (DTT) | USB | Cat#15397 |
| EDTA-free protease inhibitor cocktail | Roche | Cat#11873580001 |
| Pefabloc SC | Roche | Cat#11429876001 |
| 0.5 mm dia. Glass beads | BioSpec | Cat#11079105 |
| Endoglycosidase H (Endo H) | NEB | Cat# P0702S |
| Ponceau S | Sigma | Cat#P3504 |
| Coomassie Brilliant Blue R-250 | Bio-rad | Cat#161-0400 |
| Phosphate buffered saline (PBS) | Sigma | Cat#P3813 |
| Tween 20 | Affymetrix | Cat#T1003 |
| Amersham ECL Western Blotting Detection Reagent | Cytiva | Cat#RPN2106 |
| SuperSignalTM West Femto Maximum Sensitivity Substrate | Thermo Scientific | Cat#34096 |
| 5-Ph-IAA | Sigma | Cat#SML3574 |
| Dimethyl sulfoxide (DMSO) | Sigma | Cat#D8418 |
| Isopropylthio- β-galactoside (IPTG) | Invitrogen | Cat#15529-019 |
| Glutathione Sepharose 4B | Cytiva | Cat#17-0756-05 |
| Ni-NTA His·Bind Resin | Millipore | Cat#70666-4 |
| Strep-tactin Sepharose | IBA Lifesciences | Cat#2-1201-010 |
| Strep-tactin Magnetic Microbeads | IBA Lifesciences | Cat#6-5510-050 |
| Triton X-100 | Sigma | Cat#X100 |
| Lysozyme | Sigma | Cat#20K0956 |
| Desthiobiotin | Sigma | Cat#D1411 |
| Imidazole | Sigma | Cat#I202 |
| Bovine serum albumin (BSA) | Sigma | Cat#A7906 |
| Galactose | Sigma | Cat#G0750 |
| Raffinose | Sigma | Cat#R0250 |
| Biotin | Sigma | Cat#B4501 |
| Sucrose | USB | Cat#21938 |
| PD-10 desalting columns packed with Sephadex G-25 resin | Cytiva | Cat#17085101 |
| nProteinA Sepharose 4 Fast Flow | Cytiva | Cat#17528001 |
| Guanosine 5’-[ β, γ-imido]triphosphate trisodium salt hydrate (GMP-PNP) | Sigma | Cat#G0635 |
| Guanosine 5′-diphosphate sodium salt (GDP) | Sigma | Cat#G7127 |
| Concanavalin A (ConA) | Sigma | Cat#C7275 |
| FM4-64 Dye | Invitrogen | Cat#T13320 |
| Concanavalin A (C7275) (ConA) | Sigma | Cat#C7275 |
| Experimental models: Organisms/strains | ||
| S. cerevisiae | Lab collection and this study | Table S1 |
| Oligonucleotides | ||
| Primers | Lab collection and this study | Table S2 |
| Recombinant DNA | ||
| Plasmids | Lab collection and this study | Table S3 |
| Software and algorithms | ||
| ImageJ | NIH | https://imagej.net/ij/ |
| Prism 10 | GraphPad | https://www.graphpad.com/features |
| Fiji | NIH | https://fiji.sc |
| ChimeraX | UCSF | https://www.rbvi.ucsf.edu/chimerax |
| Other | ||
| Yeast-Display Nanobody Library (NbLib) | From the laboratory of Andrew C. Kruse, PhD, Harvard University. Distributed by Kerafast. | Cat#EF0014-FP |
| StrepMan Magnet | IBA Lifesciences | Cat#6-5650-065 |
| Econo-Column Chromatography Columns, 1.0 ×ばつ 10 cm | Bio-rad | Cat#7371012 |
| Q125 sonicator | QSONICA | Cat#Q125-110 |
| ChemiDoc Imaging System | Bio-rad | Cat#12003153 |
Experimental model and study participant details
All experiments were performed by using Saccharomyces cerevisiae BY4741 strains. Yeast cells were cultured at 25°C in YEPD or SD medium / plates for maintenance, unless specific temperature or medium was desired (e.g., 37°C , CFW medium and YEPGal medium).
Method details
Bioinformatics
The structures of Vps74 individually bound to nine of its client N-termini (Figure S5A) were generated with Alphafold2 multimer (using the default settings) powered by the COSMIC2 platform (https://cosmic-cryoem.org). Three models from each prediction were analyzed using the software ChimeraX (https://www.rbvi.ucsf.edu/chimerax). The intermolecular interactions between Vps74 and client N-termini were determined with the Contacts tool (VDW overlap≥-0.40Å) and the interaction frequency of every residue in Vps74 was recorded.
The predicted structure of Vps74 bound to Vps74InNb#4 was generated with Alphafold3 (https://alphafoldserver.com/about) using the default settings.
Yeast cell serial dilutions
Yeast cells were grown to early-mid log phase (OD660 = 0.5 - 0.8) and 107 cells were collected by centrifugation. The relationship between OD660 and cell number was derived using this Table (http://www.pangloss.com/seidel/Protocols/ODvsCells.html). Cell pellets were resuspended in ddH2O for 10-fold serial dilutions and 1/10 of the cell suspension was spotted on agar plates (106 cells in the first spot). Images of plates were taken after 48 - 72 h of incubation at the indicated temperatures. For serial dilutions conducted on calcofluor white (CFW) plates, 50 μg/mL CFW was added to the YEPD medium. For serial dilutions conducted on 5-fluoroorotic acid (5-FOA) plates, 1 mg/mL 5-FOA was added to the synthetic defined (SD) medium.
Preparation of yeast whole cell extracts from yeast cultured at 25°C and 37°C for immunoblotting of Vps74
For Figure 1D, the indicated yeast strains were grown in YEPD at 25°C to an OD660 =0.5 after which 107 cells were harvested by centrifugation and resuspended in 15% v/v trichloroacetic acid (TCA). The remaining culture was diluted in pre-warmed YEPD (37°C) to 0.2x107 cells/mL and thereafter were incubated with shaking at 37°C for 3 hours. Cells were collected by centrifugation and resuspended in 15% v/v TCA. The cell / TCA suspensions were incubated overnight at -20°C, protein precipitates were collected by centrifugation (16,000 rcf for 10 min at 4°C), and protein pellets were washed once with cold acetone (-20°C). Pellets were air dried and solubilized in 100 μl SDS-PAGE sample buffer containing 2.5% SDS, 50 mM NaOH and 5 mM DTT, and thereafter heated to 95°C for 10 min. Proteins were resolved by SDS-PAGE and immunoblotted with an anti-Vps74 antibody.
Measurement of steady-state levels of Golgi proteins in whole cell extracts by immunoblotting
Two different methods were employed to measure the steady-state levels of the enzymes. For Figures 1F, 3B, 6C, S1A–S1C, and S3, yeast cells were grown to the early-mid log phase (OD660 = 0.5-0.8) and 107 cells were collected by centrifugation. Cells were resuspended with 200 μl 100 mM NaOH and incubated for 10 min. Excess NaOH was removed by centrifugation, and cells were resuspended with 100 μl SDS sample buffer supplemented with 1x protease inhibitor cocktail, 1 mM Pefabloc SC and 5 mM DTT. Samples were then boiled for 10 min at 95°C. For the remaining Figures, the alkaline lysis step was omitted. Instead, cell pellets were directly resuspended in 100 μl SDS sample buffer supplemented with 1x protease inhibitor cocktail, 1 mM Pefabloc SC and 5 mM DTT. 30 μl acid-washed glass beads were added to cell suspensions and yeast cells were lysed by vortexing for 5 min at room temperature. Following vortexing, samples were heated at 95°C for 10 min and thereafter proteins were resolved by SDS-PAGE.
For the immunoblots of Dcr2, Kre2, Mnn5, Mnn4 and Och1, lysates were treated with Endoglycosidase H (Endo H). 20 μl of lysates in SDS sample buffer were supplemented with 3.8 μl 0.5 M potassium acetate (pH 5.6) and 10 NEB units of Endo H and incubated for 2 h at 37°C. Prior to SDS-PAGE, samples were incubated at 95°C for 5 min.
SDS-PAGE and immunoblotting
10 μl of prepared samples were loaded on 8 cm x 9cm Tris-glycine polyacrylamide gels and proteins were resolved in Tris-glycine running buffer for 1h at 200 V. For Coomassie Blue staining, gels were incubated in the staining solution (0.025% w/v Coomassie Blue R-250, 40% v/v methanol, 7% v/v acetic acid) with gentle mixing for 1 h. Gels were destained with 10% v/v acetic acid, 50% v/v methanol before imaging using a ChemiDoc Imaging System. For immunoblotting, proteins were transferred to 0.45 μm cellulose membranes, stained with Ponceau S solution (0.1% w/v Ponceau S, 5% v/v acetic acid) and images acquired with a ChemiDoc Imaging System. The stain was removed by washing the membrane in PBST (137 mM NaCl, 2.7 mM KCl, 10 mM Na2PO4, 1.8 mM KH2PO4, 0.1% v/v Tween 20) before immunoblotting. Prior to the addition of antibodies membranes were incubated in 5% w/v non-fat milk for 1 h at room temperature on an orbital shaker. Membranes were incubated with primary antibodies in 5% w/v milk for 1 h at room temperature on an orbital shaker. Excess primary antibodies were removed by washing with PBST for 5 min, three times. Membranes were incubated with secondary antibodies in 5% w/v milk for 1 h at room temperature. After washing with PBST for 5 min, three times, ECL substrate (Amersham ECL Western Blotting Detection Reagent) was added to membranes and chemiluminescent images acquired using a ChemiDoc Imaging System. For the immunoblotting of Mnn4-9myc, SuperSignalTM West Femto Maximum Sensitivity Substrate was used to enhance the weak signal.
Depletion of Pik1 with the auxin-inducible degron (AID) system
Yeast cells from an overnight culture grown in SD media +2% glucose were diluted in 10 ml of sterile SD media+2% glucose (cell density = 0.7 x 107 cells / ml) and grown for 2 h at 25 °C. Cells were collected by centrifugation, washed twice with SD media without glucose, resuspended in 2 x 5 ml SD media (2% galactose and 1% raffinose) (cell density = 0.7 x 107 cells /ml) and grown for another 2 h to induce the expression of OsTIR1. At time 0 min, a final concentration of 1 μM 5-Ph-IAA (from a 1 mM stock solution in DMSO) was added into the treatment groups and an equal volume of DMSO was added into the control groups. Cells were grown at 25 °C during the time course experiment.
At time points 0 min, 90 min and 120 min, cells from 500 μl culture were collected, kept on ice and immediately examined by fluorescent microscopy using the Zeiss LSM 980 Confocal Microscope (details are described in the Fluorescent Microscopy section), and another 400 μl cell culture were used to measure OD660 followed by the addition of 80 μl 100% w/v trichloroacetic acid (TCA) for protein precipitation. After incubating the cell / TCA suspensions on ice for 30 min, the protein pellets were collected by centrifugation (16,000 rcf for 10 min at 4°C), washed once with cold acetone (-20 °C), air dried and solubilized in SDS-PAGE sample buffer containing 2.5% SDS, 50 mM NaOH and 5 mM DTT (proteins from 105 cells / μl sample buffer). Following mixing, the samples were heated at 95°C for 5 min and proteins were resolved by SDS-PAGE.
Expression and purification of recombinant proteins from bacteria
For recombinant protein production E. coli BL21(DE3) cells were transformed with the various expression plasmids. LB media was inoculated with a single bacterial colony and cultures were incubated with shaking (200 rpm) at 37°C overnight (12 – 14 hours). Overnight cultures were diluted 1:40 with LB media and thereafter grown at 37°C and 200 rpm until the OD600 =0.6 - 0.8. Protein expression was induced with 0.2 mM IPTG at 25°C with shaking (200 rpm) overnight. Cells from 100 ml cultures were collected by centrifugation at 4,200 rcf for 10 min and washed once with PBS.
For GST-tagged fusion proteins, cell pellets were resuspended in 2 ml PBS + 10% glycerol supplemented with 1x protease inhibitor cocktail, 1 mM Pefabloc SC and 250 μg/mL lysozyme, and lysed by sonication on ice with a Q125 sonicator for 4 min, 2s on, 2s off at 40% amplitude. Following sonication cell debris was removed by centrifugation (16,000 rcf for 10 min at 4°C). To estimate the relative amounts of GST- fusion proteins in the bacterial lysates, different amounts of lysates (∼3-7 μl) were diluted in 100 μl PBS + 0.1% Triton X-100 and mixed with 20 μl Glutathione Sepharose 4B equilibrated with PBS + 0.1% Triton X-100 for 1 h at 4°C. After washing with 200 μl PBS + 0.1% Triton-X-100 three times, the beads were mixed with 30 μl SDS sample buffer supplemented with 5 mM DTT, heated at 95°C for 5 min and the amount of bound proteins was estimated by SDS-PAGE.
For (His)6-tagged fusion proteins, cell pellets were resuspended in 2 ml Ni-NTA lysis buffer (50 mM NaH2PO4, 200 mM NaCl, 10 mM imidazole, pH 8.0) supplemented with 1x protease inhibitor cocktail, 1 mM Pefabloc SC and 250 μg/mL lysozyme, and cells were lysed on ice by sonication. Debris and unlysed cells were removed by centrifugation at 16,000 rcf at 4°C for 10 min and supernatants were mixed with 0.5 ml Ni-NTA beads equilibrated with Ni-NTA lysis buffer. After 1 h mixing at 4°C, the beads were washed with 3 ml Ni-NTA wash buffer (50 mM NaH2PO4, 200 mM NaCl, 20 mM imidazole, pH 8.0) three times. Bound proteins were eluted with 500 μl PBS pH 7.4 + 250 mM imidazole, five times.
For Twin-Strep-tagged fusion proteins, proteins were purified on Strep-tactin Sepharose beads as described for (His)6-tagged proteins except that PBS + 1mM EDTA was used as the lysis and wash buffer, and PBS + 2.5 mM desthiobiotin was used to elute bound proteins.
The expression and purification of bacterially expressed N-myristoylated Arf1 was performed as previously described.15
Isolation of anti-Vps74 nanobodies from the synthetic yeast surface-display library
The isolation of anti-Vps74 nanobodies was performed as previously described35 with the following modifications. N-terminally Twin-Strep-tagged mNeon and Twin-Strep-tagged Vps74 were used in the negative and positive selection steps, respectively. For the first round of selection, 1 mL Strep-tactin Sepharose bound to 1 mg of purified Twin-Strep-tagged mNeon or Twin-Strep-tagged Vps74 was added to an Econo-Column Chromatography Column (1.0 x 10 cm). Yeast cells displaying nanobodies against Strep-tactin Sepharose and Twin-Strep-mNeon were removed by passing 5 x 109 yeast cells resuspended in 10 ml PBS + 0.1% BSA over 1 ml Strep-tactin Sepharose beads bound to purified Twin-Strep-tagged mNeon. The resulting flow through was then incubated with 1 ml of Strep-tactin Sepharose beads bound to Twin-Strep-tagged Vps74 for 1 h 4°C. Bound cells were eluted from the Twin-Strep-Vps74 column with 1 mM biotin. For the second-round selection, 100 μg Twin-Strep-Vps74 protein was bound to 100 μl Strep-tactin magnetic beads and mixed with 3 x 107 cells generated by culturing cells obtained following the first round of enrichment. A third round of nanobody selection was conducted as per the second round except that 30 μl Strep-tactin magnetic beads loaded with Twin-Strep-Vps74 were incubated with 6 x 107 cells generated by culturing cells obtained following the second round of enrichment. Yeast cells recovered from the third round of selection were spread onto the surface of -Trp plates containing 2% galactose. Cells from single colonies were incubated with 0.5 μg/μl 6His-mNeon-Vps74 fusion protein in PBS for 1 h, at 4°C, washed with PBS once and examined by fluorescent microscopy to identify cells expressing anti-Vps74 nanobodies.
Screening of inhibitory nanobodies against Vps74 in ted1Δ cells
Total DNA was extracted from yeast cells recovered after three rounds of selection and used as template to amplify nanobody-HA coding sequences by the PCR using the primers Ubi-Nb G3 and HA stop TC R. The myc-ubiquitin sequence was amplified by the PCR using the primers TPI-myc G1 and Ubi-Nb G2. The two purified PCR products were used as templates and amplified by the PCR using TPI-myc G1 and HA stop TC R to generate the myc-ubiquitin-nanobody-HA DNA fragment with flanking complementary sequences to the TPI1 promoter and CYC1 terminator. Primer information can be found in Table S2.
5 x 106 mid-log phase ted1Δ cells balanced with the TED1-URA3 plasmid (SARY8082, see Table S1) were co-transformed with 50 ng the TPI1p-CYC1t pRS415 (see Table S3) plasmid digested with HindIII and NotI, and 50 ng of purified myc-ubiquitin-nanobody-HA encoding DNA fragment. Transformants were selected on SD plates (-Leu) and single colonies were patched on SD plates (-Leu) with and without 5-FOA. Cells that failed to grow on SD containing 5-FOA plates were recovered from SD (-Leu) plates. Nanobody coding sequences were amplified by the PCR using the primers pelB-Nb pET26b G1 and HA-XhoI-6His G2 (see Table S2) and thereafter the fragment was cloned into the E. coli periplasmic expression vector pET26b, by Gibson Assembly.37
Expression and purification of nanobodies from the periplasm of bacteria
E. coli BL21(DE3) cells were transformed with pET26b plasmids (see Table S3) containing nanobody coding sequences. A single colony was used to inoculate the start culture in Terrific Broth (TB) and the culture was shaken at 37°C and 210 rpm overnight. The overnight culture was diluted 1:40 with fresh TB and grown under the same conditions. When OD600 =0.6-0.8, the culture was shifted to 25°C, and 1 mM IPTG was added to induce nanobody protein synthesis. After overnight incubation at 210 rpm, cells from 100 ml culture were collected by centrifugation at 4,200 rcf for 10 min and gently resuspended in 3 ml TSE buffer (0.2 M Tris, 0.5 M sucrose, 0.5 mM EDTA, pH 8.0). The resuspended cells were incubated at room temperature for 10 min with occasional shaking. 3 ml ice-cold ddH2O was added to trigger osmotic shock, and the mixture was incubated on ice for 10 min with occasional shaking. The lysate was supplemented with 150 mM NaCl, 2 mM MgCl2 and 20 mM imidazole, and the released periplasmic extract containing nanobodies was cleared by centrifugation at 16,000 rcf for 10 min at 4°C. The periplasmic extract was added to 0.5 ml Ni-NTA beads and mixed for 1 h at 4°C. The beads were washed with 3 ml wash buffer (20 mM HEPES, 500 mM NaCl, 20 mM imidazole, pH 7.5) three times. Nanobodies were eluted with 500 μl PBS + 250 mM imidazole five times and the elution buffer was exchanged for PBS + 10% glycerol using PD-10 desalting columns containing Sephadex G-25 resin.
Co-immunoprecipitation assay
50 x 107 mid-log phase wild-type yeast cells expressing Nb-HA were collected by centrifugation. Cells were resuspended in 1 ml lysis buffer (PBS supplemented with 1x protease inhibitor cocktail, 1 mM Pefabloc SC, 0.5 mM EDTA and 0.1% Triton X-100) and lysed with 500 μL glass beads in a bead-beater for 5 min at 4°C (1 min on, 1 min off). Yeast lysates were cleared by centrifugation at 16,000 rcf for 10 min at 4°C. A 20 μl slurry of Protein A Sepharose beads, equilibrated with lysis buffer, was mixed with yeast cell lysates for 1 h, at 4°C. Following incubation, protein-bound beads were washed with 200 μl lysis buffer three times and boiled in 50 μl SDS sample buffer supplemented with 5 mM DTT for 5 min. Bound proteins eluted from beads were analyzed by SDS-PAGE and immunoblotting.
In vitro mixing and competition assays
Bacterial lysates containing 10 ug GST-fusion proteins were mixed with 20 μl Glutathione Sepharose 4B beads equilibrated with PBS + 0.1% Triton X-100 for 1 h, at 4°C. Unbound proteins were washed away with 200 μl PBS + 0.1% Triton X-100 three times, and equimolar amounts of purified proteins of interest diluted in 100 μl PBS + 0.1% Triton X-100 were mixed with beads for 1.5 h at 4°C. Beads were washed with 200 μl PBS + 0.1% Triton X-100 three times and boiled in 30 μl SDS sample buffer supplemented with 5 mM DTT for 5 min. Bound proteins eluted from beads were analyzed by SDS-PAGE and immunoblotting.
For protein binding competition assays, 15 μl Strep-tactin Sepharose beads were bound to 10 ug of Twin-Strep-Vps74 as described above. A two-molar excess of the first protein of interest (Sac1 or Vps74InNb#4) diluted in 100 μl PBS + 0.1% Triton X-100 was mixed with loaded beads for 1h at 4°C and beads were washed with 200 μl PBS + 0.1% Triton X-100 three times. Equimolar amounts of the second protein of interest diluted in 100 μl PBS + 0.1% Triton X-100 was then mixed with Twin-Strep-Vps74 bound beads for 1.5 h at 4°C. After incubation, beads were washed with 200 μl PBS + 0.1% Triton X-100 three times and boiled in 30 μl SDS sample buffer supplemented with 5 mM DTT for 5 min. Bound proteins eluted from beads were analyzed by SDS-PAGE and immunoblotting.
For in vitro assays using purified N-myristoylated Arf1, 2 μg Arf1 was incubated in 20 μl Arf1 loading buffer (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 1 mM MgCl2, 5 mg/L BSA, 0.1% Triton X-100, pH 7.2) supplemented with 40 μM GMP-PNP for 1.5 h at 32°C. Arf1 pre-loaded with nucleotides was then used in the in vitro assays.
Staining of the yeast vacuole limiting membrane
Yeast cells were grown to the early-mid log phase (OD660 = 0.5 - 0.8) in SD media and cells from 0.5 ml of culture media were harvested and resuspended in 50 μl SD media containing 20 μM FM 4-64 dye. After incubation at 30°C for 1 h, cells were washed with 200 μl media to remove excess dye and resuspended in 1 ml media. Cells were grown at 25°C for 2 h, and thereafter examined by fluorescent microscopy.
Fluorescence microscopy
Yeast knock-in strains or transformants were grown to the early-mid log phase (OD660 = 0.5 - 0.8) in SD media and thereafter cells were collected by centrifugation. 107 cells were resuspended in 100 μl SD media and 0.8 μl of the cell suspension was applied onto a ConA-coated (200 μg/mL) glass slide (Hendley-Essex, UK). A coverslip was added on top of the slide and immobilized with nail polish. For Figures 8 and S6, samples were visualized with a Nikon Eclipse 80i microscope (Nikon instruments, Japan) equipped with a SPOR-RT3 monochrome w/o IR camera (Diagnostic Instruments, inc. Sterling Heights, MI, USA). Cells were photographed through a Nikon Plan Apo VC 100X/1.4 oil immersion objective lens. For all other Figures, images were obtained with a Zeiss LSM 980 Confocal Microscope (Carl Zeiss Microscopy GmbH, Germany) and a 100X/1.4 oil immersion objective lens. For co-localization studies fluorescent signals were acquired simultaneously. Images were processed by Fiji.38
Quantification and statistical analysis
Quantification of Coomassie Blue staining, Ponceau S staining, and immunoblots
ImageJ39 was used to measure the integrated intensities of protein bands from images captured using a ChemiDoc Imaging System. For measurements of steady-state levels of proteins from yeast whole cell extracts, the intensities of proteins of interest were normalized to the corresponding intensities of Pgk1. Intensities in the wild-type group were defined as 100%, and the intensities of other samples were normalized and expressed as percentages thereof accordingly. For the in vitro mixing and binding competition assays, the intensities of proteins of interest were normalized to the corresponding intensities of Vps74. Then the average intensity of all samples in the wild-type group or "no competition" group was defined as 100%.
Quantification of Vps74 puncta
Vps74 fluorescence puncta were quantified using the 3D-Objects Counter plug-in in Fiji software.40 In-focus cells were chosen from a bright field image to minimize measurement bias. Next, a threshold was manually applied to a fluorescence image to remove cytosolic signals from cells and isolate isotropic, round-shaped structures comprised of 5 or more pixels. Such identified "objects" were further delineated by performing connexity analysis, which allowed for the segmentation of individualized puncta. Corrections were made if necessary, following the visual inspection. Pixels with fluorescence intensity values that exceeded the threshold but did not resemble an oval-like shape, were excluded from the analysis. Finally, geometrical centers of the obtained foci were established automatically, and their number was counted. Multiple fields of view with 20 cells each were examined for every transformant.
Quantification of Vps74 puncta co-localizing with cis, medial and trans Golgi proteins
Co-localization analysis was repeated 3 times (n=3) and at least 20 cells were assessed for each technical replicate. Cells were subjected to object-based co-localization analysis using the Just Another Co-localization Plug-in (JACoP) implemented within Fiji software.40 The degree of colocalization was determined by the percentage overlap of the geometrical centers of Vps74 puncta falling inside segmented objects of the red channel (i.e., particles of the respective Golgi markers: Sed5, Sec21, Sec7).
Statistical analysis
Where only two data groups were tested, data were analysed using unpaired t-tests assuming equal variance. For data with more than two groups, one-way ANOVA followed by Tukey's or Dunnett’s multiple comparison tests were performed. For data sets with two independent variables, two-way ANOVA followed by Tukey's or Sidah’s multiple comparison tests were performed. Individual data points, means and SD are presented on graphs together with p values. Statistical analysis and graph generation were performed using Prism 10 software (GraphPad, USA).
Published: September 3, 2025
Footnotes
Supplemental information can be found online at https://doi.org/10.1016/j.isci.2025.113494.
Supplemental information
References
- 1.Banfield D.K. Mechanisms of protein retention in the Golgi. Cold Spring Harb. Perspect. Biol. 2011;3 doi: 10.1101/cshperspect.a005264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Tu L., Banfield D.K. Localization of Golgi-resident glycosyltransferases. Cell. Mol. Life Sci. 2010;67:29–41. doi: 10.1007/s00018-009-0126-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Glick B.S., Nakano A. Membrane traffic within the Golgi apparatus. Annu. Rev. Cell Dev. Biol. 2009;25:113–132. doi: 10.1146/annurev.cellbio.24.110707.175421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Glick B.S., Luini A. Models for Golgi traffic: a critical assessment. Cold Spring Harb. Perspect. Biol. 2011;3 doi: 10.1101/cshperspect.a005215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Pantazopoulou A., Glick B.S. A Kinetic View of Membrane Traffic Pathways Can Transcend the Classical View of Golgi Compartments. Front. Cell Dev. Biol. 2019;7:153. doi: 10.3389/fcell.2019.00153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Li J., Ahat E., Wang Y. Golgi Structure and Function in Health, Stress, and Diseases. Results Probl. Cell Differ. 2019;67:441–485. doi: 10.1007/978-3-030-23173-6_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rizzo R., Russo D., Kurokawa K., Sahu P., Lombardi B., Supino D., Zhukovsky M.A., Vocat A., Pothukuchi P., Kunnathully V., et al. Golgi maturation-dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3. EMBO J. 2021;40 doi: 10.15252/embj.2020107238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Schmitz K.R., Liu J., Li S., Setty T.G., Wood C.S., Burd C.G., Ferguson K.M. Golgi localization of glycosyltransferases requires a Vps74p oligomer. Dev. Cell. 2008;14:523–534. doi: 10.1016/j.devcel.2008年02月01日6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tu L., Tai W.C.S., Chen L., Banfield D.K. Signal-mediated dynamic retention of glycosyltransferases in the Golgi. Science. 2008;321:404–407. doi: 10.1126/science.1159411. [DOI] [PubMed] [Google Scholar]
- 10.Welch L.G., Peak-Chew S.-Y., Begum F., Stevens T.J., Munro S. GOLPH3 and GOLPH3L are broad-spectrum COPI adaptors for sorting into intra-Golgi transport vesicles. J. Cell Biol. 2021;220 doi: 10.1083/jcb.202106115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sardana R., Highland C.M., Straight B.E., Chavez C.F., Fromme J.C., Emr S.D. Golgi membrane protein Erd1 Is essential for recycling a subset of Golgi glycosyltransferases. eLife. 2021;10 doi: 10.7554/eLife.70774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Welch L.G., Muschalik N., Munro S. The FAM114A proteins are adaptors for the recycling of Golgi enzymes. J. Cell Sci. 2024;137:jcs262160. doi: 10.1242/jcs.262160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Brauer B.K., Chen Z., Beirow F., Li J., Meisinger D., Capriotti E., Schweizer M., Wagner L., Wienberg J., Hobohm L., et al. GOLPH3 and GOLPH3L maintain Golgi localization of LYSET and a functional mannose 6-phosphate transport pathway. EMBO J. 2024;43:6264–6290. doi: 10.1038/s44318-024-00305-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Eckert E.S.P., Reckmann I., Hellwig A., Röhling S., El-Battari A., Wieland F.T., Popoff V. Golgi phosphoprotein 3 triggers signal-mediated incorporation of glycosyltransferases into coatomer-coated (COPI) vesicles. J. Biol. Chem. 2014;289:31319–31329. doi: 10.1074/jbc.M114.608182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Tu L., Chen L., Banfield D.K. A conserved N-terminal arginine-motif in GOLPH3-family proteins mediates binding to coatomer. Traffic. 2012;13:1496–1507. doi: 10.1111/j.1600-0854.2012.01403.x. [DOI] [PubMed] [Google Scholar]
- 16.Scott K.L., Kabbarah O., Liang M.-C., Ivanova E., Anagnostou V., Wu J., Dhakal S., Wu M., Chen S., Feinberg T., et al. GOLPH3 modulates mTOR signaling and rapamycin sensitivity in cancer. Nature. 2009;459:1085–1090. doi: 10.1038/nature08109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Rizzo R., Parashuraman S., D’Angelo G., Luini A. GOLPH3 and oncogenesis: What is the molecular link? Tissue Cell. 2017;49:170–174. doi: 10.1016/j.tice.201606008. [DOI] [PubMed] [Google Scholar]
- 18.Sechi S., Frappaolo A., Karimpour-Ghahnavieh A., Piergentili R., Giansanti M.G. Oncogenic Roles of GOLPH3 in the Physiopathology of Cancer. Int. J. Mol. Sci. 2020;21:933. doi: 10.3390/ijms21030933. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Sechi S., Frappaolo A., Belloni G., Colotti G., Giansanti M.G. The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3. Oncotarget. 2015;6:3493–3506. doi: 10.18632/oncotarget.3051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Wood C.S., Schmitz K.R., Bessman N.J., Setty T.G., Ferguson K.M., Burd C.G. PtdIns4P recognition by Vps74/GOLPH3 links PtdIns 4-kinase signaling to retrograde Golgi trafficking. J. Cell Biol. 2009;187:967–975. doi: 10.1083/jcb.200909063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cai Y., Deng Y., Horenkamp F., Reinisch K.M., Burd C.G. Sac1-Vps74 structure reveals a mechanism to terminate phosphoinositide signaling in the Golgi apparatus. J. Cell Biol. 2014;206:485–491. doi: 10.1083/jcb.201404041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Wood C.S., Hung C.-S., Huoh Y.-S., Mousley C.J., Stefan C.J., Bankaitis V., Ferguson K.M., Burd C.G. Local control of phosphatidylinositol 4-phosphate signaling in the Golgi apparatus by Vps74 and Sac1 phosphoinositide phosphatase. Mol. Biol. Cell. 2012;23:2527–2536. doi: 10.1091/mbc.E12-01-0077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Audhya A., Foti M., Emr S.D. Distinct roles for the yeast phosphatidylinositol 4-kinases, Stt4p and Pik1p, in secretion, cell growth, and organelle membrane dynamics. Mol. Biol. Cell. 2000;11:2673–2689. doi: 10.1091/mbc.11.8.2673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hama H., Schnieders E.A., Thorner J., Takemoto J.Y., DeWald D.B. Direct involvement of phosphatidylinositol 4-phosphate in secretion in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 1999;274:34294–34300. doi: 10.1074/jbc.274.48.34294. [DOI] [PubMed] [Google Scholar]
- 25.Walch-Solimena C., Novick P. The yeast phosphatidylinositol-4-OH kinase pik1 regulates secretion at the Golgi. Nat. Cell Biol. 1999;1:523–525. doi: 10.1038/70319. [DOI] [PubMed] [Google Scholar]
- 26.Chen L., Tu L., Yang G., Banfield D.K. Remodeling-defective GPI-anchored proteins on the plasma membrane activate the spindle assembly checkpoint. Cell Rep. 2021;37 doi: 10.1016/j.celrep.2021.110120. [DOI] [PubMed] [Google Scholar]
- 27.Wang P., Ye Z., Banfield D.K. A novel mechanism for the retention of Golgi membrane proteins mediated by the Bre5p/Ubp3p deubiquitinase complex. Mol. Biol. Cell. 2020;31:2139–2155. doi: 10.1091/mbc.E20-03-0168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Tojima T., Suda Y., Jin N., Kurokawa K., Nakano A. Spatiotemporal dissection of the Golgi apparatus and the ER-Golgi intermediate compartment in budding yeast. eLife. 2024;13 doi: 10.7554/eLife.92900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Mesecke N., Spang A., Deponte M., Herrmann J.M. A Novel Group of Glutaredoxins in the cis-Golgi Critical for Oxidative Stress Resistance. Mol. Biol. Cell. 2008;19:2673–2680. doi: 10.1091/mbc.E07-09-0896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ram A.F., Wolters A., Ten Hoopen R., Klis F.M. A new approach for isolating cell wall mutants in Saccharomyces cerevisiae by screening for hypersensitivity to calcofluor white. Yeast. 1994;10:1019–1030. doi: 10.1002/yea.320100804. [DOI] [PubMed] [Google Scholar]
- 31.Faulhammer F., Konrad G., Brankatschk B., Tahirovic S., Knödler A., Mayinger P. Cell growth-dependent coordination of lipid signaling and glycosylation is mediated by interactions between Sac1p and Dpm1p. J. Cell Biol. 2005;168:185–191. doi: 10.1083/jcb.200407118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Faulhammer F., Kanjilal-Kolar S., Knödler A., Lo J., Lee Y., Konrad G., Mayinger P. Growth control of Golgi phosphoinositides by reciprocal localization of sac1 lipid phosphatase and pik1 4-kinase. Traffic. 2007;8:1554–1567. doi: 10.1111/j.1600-0854.2007.00632.x. [DOI] [PubMed] [Google Scholar]
- 33.Flanagan C.A., Schnieders E.A., Emerick A.W., Kunisawa R., Admon A., Thorner J. Phosphatidylinositol 4-kinase: gene structure and requirement for yeast cell viability. Science. 1993;262:1444–1448. doi: 10.1126/science.8248783. [DOI] [PubMed] [Google Scholar]
- 34.Yesbolatova A., Saito Y., Kitamoto N., Makino-Itou H., Ajima R., Nakano R., Nakaoka H., Fukui K., Gamo K., Tominari Y., et al. The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice. Nat. Commun. 2020;11:5701. doi: 10.1038/s41467-020-19532-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.McMahon C., Baier A.S., Pascolutti R., Wegrecki M., Zheng S., Ong J.X., Erlandson S.C., Hilger D., Rasmussen S.G.F., Ring A.M., et al. Yeast surface display platform for rapid discovery of conformationally selective nanobodies. Nat. Struct. Mol. Biol. 2018;25:289–296. doi: 10.1038/s41594-018-0028-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Orci L., Palmer D.J., Ravazzola M., Perrelet A., Amherdt M., Rothman J.E. Budding from Golgi membranes requires the coatomer complex of non-clathrin coat proteins. Nature. 1993;362:648–652. doi: 10.1038/362648a0. [DOI] [PubMed] [Google Scholar]
- 37.Gibson D.G., Young L., Chuang R.-Y., Venter J.C., Hutchison C.A., Smith H.O. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods. 2009;6:343–345. doi: 10.1038/nmeth.1318. [DOI] [PubMed] [Google Scholar]
- 38.Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676–682. doi: 10.1038/nmeth.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods. 2012;9:671–675. doi: 10.1038/nmeth.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Bolte S., Cordelières F.P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 2006;224:213–232. doi: 10.1111/j.1365-2818.2006.01706.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
-
•
Data reported in this paper will be shared by the lead contact upon request.
-
•
This paper does not report novel codes.
-
•
Any additional information required to reanalyze the data reported in this paper is available from the lead contact.